Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 97292

13 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
July 18, 2025
Product types
Drug
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
AEQUITA PHARMACY

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

13 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 13

Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0553-2025
Recall number
D-0553-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
290 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry

Distribution pattern

MA

drug · product 2 of 13

Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0554-2025
Recall number
D-0554-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
236 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry

Distribution pattern

MA

drug · product 3 of 13

Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0555-2025
Recall number
D-0555-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
170 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry.

Distribution pattern

MA

drug · product 4 of 13

Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0556-2025
Recall number
D-0556-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
160 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry.

Distribution pattern

MA

drug · product 5 of 13

Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0557-2025
Recall number
D-0557-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
139 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry.

Distribution pattern

MA

drug · product 6 of 13

Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0558-2025
Recall number
D-0558-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
146 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry.

Distribution pattern

MA

drug · product 7 of 13

Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0559-2025
Recall number
D-0559-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
143 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry.

Distribution pattern

MA

drug · product 8 of 13

Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 3 x 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0560-2025
Recall number
D-0560-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
155 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry.

Distribution pattern

MA

drug · product 9 of 13

Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0561-2025
Recall number
D-0561-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
221 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry.

Distribution pattern

MA

drug · product 10 of 13

Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0562-2025
Recall number
D-0562-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
194 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry.

Distribution pattern

MA

drug · product 11 of 13

Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0563-2025
Recall number
D-0563-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
190 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry.

Distribution pattern

MA

drug · product 12 of 13

Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0564-2025
Recall number
D-0564-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
176 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry.

Distribution pattern

MA

drug · product 13 of 13

Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

D-0565-2025
Recall number
D-0565-2025
Initiated
July 18, 2025
Classification
Class II
Status
Ongoing
Recalling firm
AEQUITA PHARMACY
Quantity
158 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls.

Code information

All Lots within expiry.

Distribution pattern

MA